Faes Farma, S.A.
Records under this name other than the patents Faes Farma, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 5 of 5 · Back to Faes Farma, S.A.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,370,742 | Process and Intermediates for the Preparation of Bilastine Lapsed on the fee record Ended Jun 28, 2026 · High confidence | Lapsed on the fee record | Ended Jun 28, 2026 | High confidence |
| US 7,612,095 | Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-αα-dimethyl-benzeneacetic acid Term ended Term ended Sep 6, 2023 · From the USPTO record | Term ended | Term ended Sep 6, 2023 | From the USPTO record |
| US 7,781,594 | 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases Lapsed on the fee record Ended Aug 24, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 24, 2018 | From the USPTO record |
| US 8,492,411 | 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases Lapsed on the fee record Ended Jul 23, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jul 23, 2017 | From the USPTO record |
| US 5,877,187 | Benzimidazole derivatives with antihistaminic activity Term ended Term ended no later than Mar 2, 2019 · Low confidence | Term ended | Term ended no later than Mar 2, 2019 | Low confidence |